Completed PHASE1 INTERVENTIONAL 2-arm NCT01225523

Perioperative Vs. Preoperative Chemotherapy With Surgery in the Squamous Carcinoma of Esophagus

Perioperative Versus Preoperative Chemotherapy With Surgery in Patients With Locoregional Squamous Carcinoma of Esophagus

Sponsor: Xi'an Jiaotong University

Conditions Esophagus Disorders Squamous Carcinoma of Esophagus

Interventions Paclitaxel; Cisplatin; 5-Fluorouracil Paclitaxel; Cisplatin; 5-Fluorouracil; Capecitabine

Updated 7 times since 2017 Last updated: Oct 20, 2010 Started: Jan 31, 1997 Primary completion: Dec 31, 2008 Completion: Jan 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01225523, this PHASE1 trial focuses on Esophagus Disorders and Squamous Carcinoma of Esophagus and remains completed. Sponsored by Xi'an Jiaotong University, it has been updated 7 times since 1997, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

7 versions recorded

Feb 2025 — Present [monthly]

Completed PHASE1
Sep 2024 — Feb 2025 [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Sep 2020 — Jan 2021 [monthly]

Completed PHASE1

▶ Show 2 earlier versions

Jun 2018 — Sep 2020 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Jan 1997

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Xi'an Jiaotong University

Data source: Xi'an Jiaotong University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Xi'an, China